Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Vaccine symbols : Amrs save search
AMYRIS AND IMMUNITYBIO COMPLETE JOINT VENTURE FOR NEXT GENERATION COVID-19 RNA VACCINE
Published: 2022-01-03 (Crawled : 13:30) - prnewswire.com
IBRX | $4.92 -6.11% -6.5% 3.5M
|
Manufacturing
|
| O: 1.15%
H: 0.0%
C: 0.0%
AMRS | $0.05 -21.88% -16.36% 47M
|
Process Industries
|
| O: 3.14%
H: 14.14%
C: 5.02%
covid-19 covid vaccine
ImmunityBio Announces Completion of $470 Million Post-merger Financing to Fund Late-stage Cancer Clinical Trials, Phase 3 of COVID T-Cell Universal Boost Vaccine Trial and Provides Update on Bladder Cancer BLA Filing
Published: 2021-12-20 (Crawled : 14:30) - biospace.com/
IBRX | $4.92 -6.11% -6.5% 3.5M
|
Manufacturing
|
| O: 1.53%
H: 1.2%
C: -2.41%
AMRS | $0.05 -21.88% -16.36% 47M
|
Process Industries
|
| O: -2.79%
H: 1.93%
C: -3.72%
als bladder cancer trials trial covid cel clinical trials cancer vaccine phase 3 merge t-cell bladder
Mix-and-Match Vaccine Platform May Boost Immune Response & Duration
Published: 2021-12-03 (Crawled : 06:00) - biospace.com/
AMRS | $0.05 -21.88% -16.36% 47M
|
Process Industries
|
| O: -5.61%
H: 0.0%
C: 0.0%
vaccine platform response
ImmunityBio Expands Vaccine Program to Accelerate Use of “Mix-and-Match” Technologies in Developing and Manufacturing Next-Generation COVID-19 Vaccines
Published: 2021-11-18 (Crawled : 21:00) - biospace.com/
IBRX | $4.92 -6.11% -6.5% 3.5M
|
Manufacturing
|
| O: 0.0%
H: 0.07%
C: -6.31%
AMRS | $0.05 -21.88% -16.36% 47M
|
Process Industries
|
| O: -0.69%
H: 2.92%
C: -0.7%
covid vaccine
Amyris Announces JV Partnership With ImmunityBio For Next Generation COVID-19 RNA Vaccine
Published: 2021-11-08 (Crawled : 13:15) - prnewswire.com
IBRX | $4.92 -6.11% -6.5% 3.5M
|
Manufacturing
|
| O: -1.84%
H: 2.46%
C: -0.23%
AMRS | $0.05 -21.88% -16.36% 47M
|
Process Industries
|
| O: -2.0%
H: 0.49%
C: -8.46%
covid partnership vaccine covid-19
Amyris Achieves Promising In-Vivo Results For Intranasal Delivery Of RNA/NLC Vaccine
Published: 2021-08-20 (Crawled : 12:15) - prnewswire.com
AMRS | $0.05 -21.88% -16.36% 47M
|
Process Industries
|
| O: -0.25%
H: 0.0%
C: 0.0%
results vaccine liver
Amyris Completes First Major License For Leading RNA Vaccine Advancing Technology To Human Trials
Published: 2021-07-01 (Crawled : 12:15) - prnewswire.com
AMRS | $0.05 -21.88% -16.36% 47M
|
Process Industries
|
| O: 1.34%
H: 3.01%
C: 2.41%
vaccine license technology trial
Amyris Announces Positive Pre-Clinical Results For COVID-19 RNA Vaccine Platform With Advantaged Manufacturing, Storage And Distribution Characteristics
Published: 2021-02-22 (Crawled : 15:00) - biospace.com/
AMRS | $0.05 -21.88% -16.36% 47M
|
Process Industries
|
| O: 1.79%
H: 12.61%
C: 1.39%
covid positive results vaccine distribution preclinical pre-clinical
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.